Announcements Trials
Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Prostatic Neoplasms 4Squamous Cell Carcinoma of Head and Neck 2Meningioma 2Glioma 2Glioblastoma 2Breast Neoplasms 2Stage I Prostate Adenocarcinoma AJCC v7 1Small Cell Lung Carcinoma 1Sarcoma 1Resectable Lung Non-Small Cell Carcinoma 1Pituitary Neoplasms 1Pancreatic Neoplasms 1Oligodendroglioma 1Neurilemmoma 1Nerve Sheath Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Ion Beam Radiation Therapy for Tumor Patients 1Gastroesophageal Junction Adenocarcinoma 1Clinical Stage I Esophageal Adenocarcinoma AJCC v8 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Brain Neoplasms 1Astrocytoma 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

pembrolizumab 90Blood Specimen Collection 41Cyclophosphamide 37Bevacizumab 36Nivolumab 35Standard of Care 32Carboplatin 31Surveys and Questionnaires 29Paclitaxel 27atezolizumab 25Exercise 25Pemetrexed 24Gemcitabine 24Cisplatin 23Fluorouracil 22Radiotherapy 20Leucovorin 20Dexamethasone 20Docetaxel 19Oxaliplatin 18Rituximab 16Irinotecan 16Cetuximab 16dostarlimab 15Drug Therapy 15Doxorubicin 15Ipilimumab 14Biopsy 14130-nm albumin-bound paclitaxel 14fludarabine 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Protons × 1 year × Clear all
NCT02436941 2026-05-08

Radiation Medicine Patient Registry, Loma Linda University Medical Center

Loma Linda University

Enrolling by invitation
75,000 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡